A team of researchers have been awarded over £1m to explore the capabilities of quantum computing for developing new drugs for myotonic dystrophy.

The University of Nottingham, with partners Phasecraft and QuEra Computing Inc. are one of only 12 successful teams worldwide to be selected for funding as part of the Wellcome Leap $50 million supported challenge program Quantum for Bio(Q4Bio), that aims to accelerate applications of quantum computing to address pressing human health challenges.

Read the full article here:

https://www.nottingham.ac.uk/news/researchers-take-a-quantum-leap-into-drug-development-for-muscle-wasting-disease